Latest News
29-Nov-2022 Bharat Bio’s Intranasal Vax Approved as Booster Dose
28-Nov-2022 Medley-Cipla Deal Talks Called off Over Valuation Issues
22-Nov-2022 MO Alts Plans $200-m Healthcare Investment
22-Nov-2022 Sputnik Takers in a Fix as Russian Vax is Still Not Widely Accepted
18-Nov-2022 Welspun’s Set to Acquire 70% Debt of Sintex BAPL
  more...
Latest Reports
Nov-22 Specialty Chemicals - Motilal Oswal  
Nov-22 Sharp decline in volume for Oct-22 - Emkay Research  
Oct-22 Margins remain under pressure; revenue growth to recover - Nirmal Bang  
Oct-22 Jul-Sep'22 Earnings Preview - Prabhudas Lilladher  
Sep-22 Brand matters - Nirmal Bang  
  more...

Quarterly Summary September-2022
Desc Current Previous Per.Chg
Sales 29160.3 26052.3 11.9
Otherincome 757.7 1041.6 -27.3
Expense 21540.6 19688.0 9.4
RawMaterial 9242.2 8692.6 6.3
StaffCost 3762.1 3431.5 9.6
ExciseDuty 0.0 0.0 -100.0
OtherExp 6589.9 5859.8 12.5
Interest 371.7 353.0 5.3
GrossProfit 8569.5 7210.3 18.9
Depreciation 1525.8 1339.7 13.9
Tax 1610.4 1260.4 27.8
NetProfit 5398.4 5071.1 6.5
Total.Comp 50 -- --
Source: ETIG Database

Sectoral Companies As on 29 Nov 2022
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 251818.53
Cipla 90490.48
Divi's Lab 89558.85
Dr.Reddy's 74134.96
Torrent Phar 55255.41
Abbott (I) 42843.08
Zydus Life 41500.80
Alkem Labora 37363.56
Lupin 34144.90
Biocon 33868.93
Gland Pharma 30957.01
Aurobindo Ph 27338.09
Syngene Intl 24125.94
  click here for the complete list